about
Role of proteinase-activated receptor-2 in anti-bacterial and immunomodulatory effects of interferon-γ on human neutrophils and monocytesFrom synovial tissue to peripheral blood: myeloid related protein 8/14 is a sensitive biomarker for effective treatment in early drug development in patients with rheumatoid arthritisStaphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils.IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases.Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infectionStaphylococcus aureus Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome.Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks?Phagocyte-derived S100 proteins in autoinflammation: putative role in pathogenesis and usefulness as biomarkers.Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling.Alarming consequences - autoinflammatory disease spectrum due to mutations in proline-serine-threonine phosphatase-interacting protein 1.Alarmins firing arthritis: Helpful diagnostic tools and promising therapeutic targets.The danger from within: alarmins in arthritis.Genotype-phenotype and genotype-origin correlations in children with mediterranean fever in Germany - an AID-net study.[Genetic fever syndromes. Hereditary recurrent (periodic) fever syndromes].Elevated S100A8/A9 and S100A12 Serum Levels Reflect Intraocular Inflammation in Juvenile Idiopathic Arthritis-Associated Uveitis: Results From a Pilot Study.The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis.HSV-1 viremia as a potential cause of febrile neutropenia in an immunocompromised child.Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases.[Methotrexate in the therapy of juvenile idiopathic arthritis].S100A12 as diagnostic tool in the differential diagnosis of sJIA associated MAS vs. hereditary or acquired HLH.A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8/14 protein.Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany.The German version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).Subcutaneous infection with S. aureus in mice reveals association of resistance with influx of neutrophils and Th2 response.MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis.Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN-αPhagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative studyAlarmins of the S100-Family in Juvenile Autoimmune and Auto-Inflammatory DiseasesTreatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up Study
P50
Q24299943-C5336EE7-3B25-4AEF-95E6-9D523E192A63Q28542641-2810110A-442B-4D1D-B9EE-ED442CFC128AQ33523802-9AA9FADB-A5CF-4EF3-95DA-97485F833783Q35291353-AD76CD4A-FC7D-4EBC-9AB2-7E5192155319Q36090341-68BABDFB-B935-44C3-9091-08CCFF56F06FQ36332700-BD0EC1EE-84A1-46C2-9709-2FDF73BA71C3Q37093920-3F79731E-D1BA-4695-82E4-B5AFD0579A2DQ38069918-2DCA4FF9-FEA5-4AC2-B78A-E34F2AB8D625Q38301869-5498ABE9-5FE2-4E08-AECF-0D549FDF3042Q38837257-6BA5B835-9968-4EED-9DF9-CEB8CCAE13A1Q38962072-1B94CB51-21F1-4144-801E-D6AB679424F9Q38979165-28E01556-3B87-4C30-98FC-273E30377437Q40230505-138C2212-A592-4F68-862C-310BB21DE609Q40252367-730D3BA9-D142-4C07-B6A8-03ED4935B8FAQ40255552-DE3909AF-88FA-4766-B380-75DD26C4E8C3Q40298553-1258D951-6E2B-42E2-87F7-138AFC473C19Q40372548-9A09FE7B-45DA-458E-B82A-F779ED5804FFQ41195612-0046952D-AB58-4D93-9B26-593EF96DBD29Q42969813-731D499A-A753-4E12-9CC4-0E647ADDF148Q46449351-0DD7D601-778C-47FE-9460-CFFF59A61F64Q46823418-D22CCEE4-1F92-4D7C-920A-257CDEFA45F6Q48514200-905D5C24-EC83-4602-A8F7-B805FDE0A294Q52594888-65F79428-82CC-433D-8FC1-2BADDDE70650Q52767088-F82954F3-1046-4155-B311-D905CA08AF9CQ54501729-D383E70D-8A83-4CDD-9BF0-90F14593C6D5Q56539637-9668B417-F4A5-43E6-800F-05A8530ECDCCQ58429085-F0941C66-1962-4996-9CC7-C02BF0C59ACFQ64266535-E2F3A1D9-9BF7-4354-9342-892C6365BB6AQ92219527-2A4DAB61-21A5-4AE2-BFF1-59091F654543
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dirk Holzinger
@ast
Dirk Holzinger
@en
Dirk Holzinger
@es
Dirk Holzinger
@nl
Dirk Holzinger
@sl
type
label
Dirk Holzinger
@ast
Dirk Holzinger
@en
Dirk Holzinger
@es
Dirk Holzinger
@nl
Dirk Holzinger
@sl
prefLabel
Dirk Holzinger
@ast
Dirk Holzinger
@en
Dirk Holzinger
@es
Dirk Holzinger
@nl
Dirk Holzinger
@sl
P214
P106
P1153
9940315100
P214
P31
P496
0000-0002-8062-8820
P735
P7859
viaf-33190971